Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Non-Current Debt (2023 - 2025)

Historic Non-Current Debt for Utah Medical Products (UTMD) over the last 8 years, with Q3 2025 value amounting to $241000.0.

  • Utah Medical Products' Non-Current Debt changed N/A to $241000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $241000.0, marking a year-over-year change of. This contributed to the annual value of $282000.0 for FY2024, which is 440.68% down from last year.
  • Latest data reveals that Utah Medical Products reported Non-Current Debt of $241000.0 as of Q3 2025.
  • Utah Medical Products' 5-year Non-Current Debt high stood at $295000.0 for Q4 2023, and its period low was $241000.0 during Q3 2025.
  • Moreover, its 3-year median value for Non-Current Debt was $275500.0 (2024), whereas its average is $271750.0.
  • Examining YoY changes over the last 5 years, Utah Medical Products' Non-Current Debt showed a top increase of 440.68% in 2024 and a maximum decrease of 440.68% in 2024.
  • Over the past 3 years, Utah Medical Products' Non-Current Debt (Quarter) stood at $295000.0 in 2023, then decreased by 4.41% to $282000.0 in 2024, then dropped by 14.54% to $241000.0 in 2025.
  • Its Non-Current Debt stands at $241000.0 for Q3 2025, versus $269000.0 for Q1 2025 and $282000.0 for Q4 2024.